Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.
作者信息
Robbins Hilary A, Callister Matthew, Sasieni Peter, Quaife Samantha L, Cheung Li C, Brennan Paul, Katki Hormuzd A, Berg Christine D, Baldwin David, Johansson Mattias
机构信息
International Agency for Research on Cancer, Lyon, France.
Leeds Teaching Hospitals, Leeds, UK.
出版信息
Lancet Respir Med. 2019 Aug;7(8):655-656. doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7.
Abstract
摘要
相似文献
1
Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol.国家肺癌筛查试验中的获益与危害：采用现代管理方案的预期结果
Lancet Respir Med. 2019 Aug;7(8):655-656. doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7.
2
Brief History of Lung Cancer Screening Including the National Lung Screening Trial.肺癌筛查简史，包括国家肺癌筛查试验。
Semin Roentgenol. 2017 Jul;52(3):125-128. doi: 10.1053/j.ro.2017.06.006. Epub 2017 Jun 3.
3
Low-Dose Computed Tomography for Lung Cancer Screening: The Protocol and The Dose.低剂量计算机断层扫描用于肺癌筛查：方案与剂量
Semin Roentgenol. 2017 Jul;52(3):132-136. doi: 10.1053/j.ro.2017.06.002. Epub 2017 Jun 3.
4
What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?低剂量计算机断层扫描用于肺癌筛查的利弊平衡是什么？
J R Soc Med. 2021 Apr;114(4):164-170. doi: 10.1177/0141076821991108. Epub 2021 Mar 10.
5
Elements of a Lung Cancer Screening Program.肺癌筛查计划的要素。
Semin Roentgenol. 2017 Jul;52(3):129-131. doi: 10.1053/j.ro.2017.06.004. Epub 2017 Jun 5.
6
Lung Computed Tomography Screening Reporting and Data System Version 1.0.肺部计算机断层扫描筛查报告与数据系统1.0版
Semin Roentgenol. 2017 Jul;52(3):137-142. doi: 10.1053/j.ro.2017.06.009. Epub 2017 Jun 5.
7
Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage.权衡低剂量计算机断层扫描肺癌筛查的利弊：医疗保险的覆盖选项。
Ann Intern Med. 2014 Sep 16;161(6):445-6. doi: 10.7326/M14-1352.
8
Lung cancer screening: one step forward.肺癌筛查：向前迈进了一步。
Cleve Clin J Med. 2012 May;79(5):306. doi: 10.3949/ccjm.79b.12005.
9
Estimating overdiagnosis of lung cancer.估算肺癌的过度诊断情况。
Ann Intern Med. 2013 Apr 16;158(8):635. doi: 10.7326/0003-4819-158-8-201304160-00013.
10
Estimating overdiagnosis of lung cancer--reply.肺癌过度诊断的评估——回复
Ann Intern Med. 2013 Apr 16;158(8):635-6. doi: 10.7326/0003-4819-158-8-201304160-00014.
引用本文的文献
1
Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be Addressed.低剂量CT肺癌筛查：我们在ITALUNG二十年中学到了什么以及仍有待解决的问题
Diagnostics (Basel). 2023 Jun 28;13(13):2197. doi: 10.3390/diagnostics13132197.
2
Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer.早期肺癌筛查、诊断及生物标志物检测的障碍与挑战评估
Cancers (Basel). 2023 Mar 3;15(5):1595. doi: 10.3390/cancers15051595.
3
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.在英国，一项针对具有肺癌风险的、种族和社会经济背景多样化人群的、提供低剂量 CT 肺癌筛查的肺部健康检查邀请参与情况的前瞻性纵向队列研究（SUMMIT）：一项针对具有肺癌风险的、种族和社会经济背景多样化人群的、提供低剂量 CT 肺癌筛查的肺部健康检查邀请参与情况的前瞻性纵向队列研究。
Lancet Public Health. 2023 Feb;8(2):e130-e140. doi: 10.1016/S2468-2667(22)00258-4.
4
Are Skeletal Muscle Changes during Prolonged Space Flights Similar to Those Experienced by Frail and Sarcopenic Older Adults?长期太空飞行期间骨骼肌的变化与体弱和患有肌肉减少症的老年人所经历的变化相似吗？
Life (Basel). 2022 Dec 19;12(12):2139. doi: 10.3390/life12122139.
5
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.低剂量计算机断层扫描（LDCT）筛查对肺癌相关死亡率的影响。
Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2.
6
Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology.低剂量 CT 肺癌筛查：意大利胸放射学会立场文件。
Radiol Med. 2022 May;127(5):543-559. doi: 10.1007/s11547-022-01471-y. Epub 2022 Mar 20.
7
The Role of Programmed Cell Death Receptor 1 in Lung Cancer.程序性细胞死亡受体 1 在肺癌中的作用。
In Vivo. 2022 Mar-Apr;36(2):1007-1012. doi: 10.21873/invivo.12794.
8
A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil.一项比较巴西肺癌筛查资格策略的建模分析。
EClinicalMedicine. 2021 Nov 1;42:101176. doi: 10.1016/j.eclinm.2021.101176. eCollection 2021 Dec.
9
What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?低剂量计算机断层扫描用于肺癌筛查的利弊平衡是什么？
J R Soc Med. 2021 Apr;114(4):164-170. doi: 10.1177/0141076821991108. Epub 2021 Mar 10.
10
Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action.基层医疗中肺癌筛查指南的实施：行动呼吁
Ann Fam Med. 2020 May;18(3):196-201. doi: 10.1370/afm.2541.
本文引用的文献
1
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.在MILD试验中，延长肺癌筛查可降低10年死亡率：肺癌筛查疗效的新证实
Ann Oncol. 2019 Oct 1;30(10):1672. doi: 10.1093/annonc/mdz169.
2
Low-dose CT for lung cancer screening.低剂量CT用于肺癌筛查。
Lancet Oncol. 2018 Mar;19(3):e131-e132. doi: 10.1016/S1470-2045(18)30121-9.
3
European position statement on lung cancer screening.欧洲肺癌筛查立场声明。
Lancet Oncol. 2017 Dec;18(12):e754-e766. doi: 10.1016/S1470-2045(17)30861-6.
4
British Thoracic Society guidelines for the investigation and management of pulmonary nodules.英国胸科学会肺结节的调查与管理指南。
Thorax. 2015 Aug;70 Suppl 2:ii1-ii54. doi: 10.1136/thoraxjnl-2015-207168.
5
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.国家肺癌筛查试验中Lung-RADS的表现：一项回顾性评估
Ann Intern Med. 2015 Apr 7;162(7):485-91. doi: 10.7326/M14-2086.
6
Overdiagnosis in low-dose computed tomography screening for lung cancer.低剂量计算机断层扫描筛查肺癌中的过度诊断。
JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738.
7
Targeting of low-dose CT screening according to the risk of lung-cancer death.根据肺癌死亡风险进行低剂量 CT 筛查的目标。
N Engl J Med. 2013 Jul 18;369(3):245-254. doi: 10.1056/NEJMoa1301851.
8
Reduced lung-cancer mortality with low-dose computed tomographic screening.低剂量计算机断层扫描筛查可降低肺癌死亡率。
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
Zotero 插件